Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,694 | -13,400 | -7,008 | -13,310 | -9,812 |
| Depreciation Amortization | 383 | 244 | 93 | 400 | 279 |
| Accounts receivable | 215 | 208 | -37 | N/A | 12 |
| Accounts payable and accrued liabilities | 63 | 345 | 304 | N/A | 83 |
| Other Working Capital | 903 | 837 | -124 | -240 | -24 |
| Other Operating Activity | 4,260 | 3,229 | 2,747 | 510 | 274 |
| Operating Cash Flow | $-14,870 | $-8,537 | $-4,025 | $-12,640 | $-9,188 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -819 | -545 | -297 | -380 | -181 |
| Investing Cash Flow | $-819 | $-545 | $-297 | $-380 | $-181 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,877 | 14,877 | N/A | N/A | 8,494 |
| Debt Repayment | -2,273 | -2,273 | -454 | N/A | -1,364 |
| Common Stock Issued | 69,546 | 24 | 21 | N/A | 2 |
| Other Financing Activity | -3,074 | -1,107 | 0 | 6,680 | 0 |
| Financing Cash Flow | $79,076 | $11,521 | $-433 | $6,680 | $7,132 |
| Beginning Cash Position | 17,505 | 17,505 | 17,505 | 23,850 | 23,854 |
| End Cash Position | 80,892 | 19,944 | 12,750 | 17,500 | 21,617 |
| Net Cash Flow | $63,387 | $2,439 | $-4,755 | $-6,340 | $-2,237 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,870 | -8,537 | -4,025 | -12,640 | -9,188 |
| Capital Expenditure | -819 | -545 | -297 | N/A | -181 |
| Free Cash Flow | -15,689 | -9,082 | -4,322 | -12,640 | -9,369 |